Comments

BridgeBio Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BBIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$39.78

0.130.33%

At close: -

$39.78

0.000.00%

After Hours: Jun 13, 4:00 PM EDT

BridgeBio Pharma (BBIO) Forecast

News Earnings BridgeBio Pharma (BBIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

BridgeBio Pharma Stock Price, Quotes and Forecasts | NASDAQ:BBIO | Benzinga

Explore BridgeBio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBIO.

Open	$38.96
Close	$39.78
Volume / Avg.	2.64M / 2.86M
Day Range	$38.57 - $39.82
52 Wk Range	21.62 - 40.40
Market Cap	$7.55B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	19.52%
Days to Cover	10.13

Recent News

The Smart Money Is Buying These 10 Stocks

Tim Melvin

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

Alnylam analysts highlight Amvuttra's strong launch positioning and limited tariff risk, with bullish ratings maintained despite early launch volatility.

Vandana Singh

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to market it.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Feb

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$38.96
Close	$39.78
Volume / Avg.	2.64M / 2.86M
Day Range	$38.57 - $39.82
52 Wk Range	21.62 - 40.40
Market Cap	$7.55B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	19.52%
Days to Cover	10.13

About BridgeBio Pharma Inc

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and deliver...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BridgeBio Pharma (BBIO) stock?

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Who are BridgeBio Pharma (BBIO) competitors?

Other companies in BridgeBio Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

BridgeBio Pharma has a consensus price target of $49.26.

What is the current price for BridgeBio Pharma (BBIO)?

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $39.78 last updated June 13, 2025 at 4:00 PM EDT.

Does BridgeBio Pharma (BBIO) pay a dividend?

There are no upcoming dividends for BridgeBio Pharma.

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

BridgeBio Pharma’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is BridgeBio Pharma (BBIO) going to split?

There is no upcoming split for BridgeBio Pharma.

What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.